Accenture reveals $74.2 billion fiscal revenue
Accenture (NYSE:ACN) reported fiscal fourth-quarter revenue of $18.7 billion and full-year fiscal 2026 revenue of $74.2 billion, with full-year diluted earnings per share increasing 12% to $13.56.
Every story in this section, newest first — page 40 of 373.
Accenture (NYSE:ACN) reported fiscal fourth-quarter revenue of $18.7 billion and full-year fiscal 2026 revenue of $74.2 billion, with full-year diluted earnings per share increasing 12% to $13.56.
McCormick (NYSE:MKC) reported third-quarter fiscal 2026 net sales growth of 17.4% and reaffirmed its full-year outlook, with adjusted earnings per share increasing to $0.86 from $0.85.
Magnolia Oil & Gas (NYSE:MGY) provided an interim financial and operational update following the completion of its acquisition of WildFire Energy, highlighting integration progress, debt reduction and production plans.
Enerflex (NYSE:EFXT) won a contract to supply approximately 450 megawatts of natural gas-fired power generation systems for a North American data center developer, with deliveries planned between 2027 and 2028.
American Battery Technology Company (NASDAQ:ABAT) received U.S. Department of Commerce approval to export up to $100 million of recycled black mass under specified terms following new federal export controls for critical battery materials.
Global Net Lease (NYSE:GNL) declared a common stock dividend of $0.190 per share for the fourth quarter of 2026, with payment scheduled for October 16, 2026.
Beam Global (NASDAQ:BEEM) announced that its Beam Europe subsidiary secured approximately $4 million in smart city infrastructure orders during the third quarter of 2026 across European markets.
Acuity (NYSE:AYI) reported fiscal fourth-quarter net sales of $1.2 billion for the quarter ended August 31, 2026, with diluted earnings per share rising 56% to $5.63.
Oil prices rose around 2% on Thursday after China suspended oil product exports to regions outside Hong Kong and Macau, adding pressure to global fuel markets affected by supply disruptions.
United Therapeutics (NASDAQ:UTHR) announced that a Delaware federal court found Liquidia’s Yutrepia infringes two claims of a patent covering inhaled treprostinil treatment for pulmonary hypertension associated with interstitial lung disease (PH-ILD).
STARZ (NASDAQ:STRZ) warned that Verizon Fios customers may lose access to its services unless the companies reach a new distribution agreement, affecting STARZ channels, On Demand content and the STARZ app through Fios.
Li Auto (NASDAQ:LI) delivered 31,817 vehicles in September 2026, with cumulative deliveries reaching 1,833,651 vehicles as the company expanded its battery-electric vehicle lineup.
Tigo Energy (NASDAQ:TYGO) announced it will showcase its GO Optimized Energy Storage Solution at Smart Energy Forum 2026 in Prague, following increased deployment of its solar technology across the Czech market.
NIO (NYSE:NIO) delivered 37,408 vehicles in September 2026, representing a 7.7% year-over-year increase across its NIO, ONVO and FIREFLY vehicle brands.
Regeneron (NASDAQ:REGN) expanded its antibody alliance with Sanofi through an agreement covering four long-acting antibody candidates and a $1 billion upfront payment to Regeneron.
XPENG (NYSE:XPEV) delivered 41,256 vehicles in September 2026, with monthly deliveries increasing 5% compared with the previous month and third-quarter deliveries reaching 118,390 vehicles.
Oculis (NASDAQ:OCS) joined the National Multiple Sclerosis Society’s Campaign to End MS as an industry partner focused on advancing research and care related to vision problems in multiple sclerosis.
ADS-TEC Energy (NASDAQ:ADSE) reported unaudited first-half 2026 revenue of €7.4 million for the six months ended June 30, 2026, compared with €14.6 million in the prior-year period.
Ares Management (NYSE:ARES) announced that its Ares Alternative Credit funds participated in a Plenitude ownership and governance restructuring, increasing its stake after a combined capital contribution of approximately €1.5 billion with Eni.
Pfizer (NYSE:PFE) reported Phase 2 results showing that investigational tilrekimig achieved its primary endpoint by producing statistically significant increases in EASI-75 responses compared with placebo at Week 16 in adults with moderate-to-severe atopic dermatitis.
Inseego (NASDAQ:INSG) completed its acquisition of Nokia’s (NYSE:NOK) fixed wireless access business, expanding its wireless broadband operations across Europe, the Middle East, Asia, Oceania and the Americas.
United Therapeutics (NASDAQ:UTHR) shares rose 13% to $543.99 after a Delaware federal court denied Liquidia’s motion to strike a defense argument in a patent infringement case involving Tyvaso and Yutrepia.
Tiziana Life Sciences (NASDAQ:TLSA) submitted a request to the U.S. Food and Drug Administration for Orphan Drug Designation for intranasal foralumab as a potential treatment for multiple system atrophy (MSA).
Kailera Therapeutics (NASDAQ:KLRA) announced completion of enrollment across three global Phase 3 trials evaluating investigational once-weekly ribupatide injection in people with obesity or overweight.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy